Angze Taiying No. 6 Private Equity Securities Investment, managed by Shanghai Angze Private Fund Management Co., Ltd. signed Share Transfer Agreement to acquire 6.88% stake in Thalys Medical Technology Group Inc. (SHSE:603716) from Saihai (Shanghai) Health Technology Co., Ltd. for CNY 160 million on December 15, 2022.
Thalys Medical Technology Group Corporation
Equities
603716
CNE1000030C3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.27 CNY | +6.13% | +16.69% | -34.45% |
1st Jan change | Capi. | |
---|---|---|
-34.45% | 181M | |
-3.54% | 9.4B | |
+31.91% | 1.92B | |
-2.39% | 1.39B | |
-6.73% | 1.18B | |
-16.69% | 856M | |
+0.81% | 470M | |
+3.39% | 437M | |
-48.57% | 360M | |
-22.36% | 333M |
- Stock Market
- Equities
- 603716 Stock
- News Thalys Medical Technology Group Corporation
- Angze Taiying No. 6 Private Equity Securities Investment, managed by Shanghai Angze Private Fund Management Co., Ltd. signed Share Transfer Agreement to acquire 6.88% stake in Thalys Medical Technology Group Inc. from Saihai Health Technology Co., Ltd. for CNY 160 million.